Successful aging depends in part on delaying age-related disease (ARD) onsets until later in life. Conditions including coronary artery disease, Alzheimer's disease, prostate cancer and type 2 diabetes are moderately heritable. Genome Wide Association Studies (GWAS) have identified many risk associated single nucleotide polymorphisms (SNPs) for these conditions, but much heritability remains unaccounted for. Nevertheless a great deal is being learned: here we review ARD associated SNPs and identify key underlying pathways including lipid handling, specific immune processes, early tissue development and cell cycle control. Most ARD associated SNPs do not affect coding regions of genes or protein makeup, but instead influence regulation of gene expression. Recent evidence indicates that evolution of gene regulatory sites is fundamental to interspecies differences. Animal models relevant to human aging may therefore need to focus more on gene regulation rather than testing major disruptions to fundamental pathway genes.
Introduction
While there is much debate about the processes driving human aging, there is little doubt that genetic influences play a significant role 1 . Humans clearly live very much longer than the currently favored laboratory models of aging, and such interspecies differences in reproductively 'fit' lifespan must have an inherited genetic foundation.
Within human populations, environmental and behavioral exposures are important but at least a quarter of life expectancy variation in twin or family studies is attributable to inherited genetic or epigenetic factors 2 . Age related conditions such as type 2 diabetes, myocardial infarction, common cancers and Alzheimer's disease typically have onsets after the fourth decade of life; 'successful' agers delay these onsets until relatively late in life 3 . Many aging traits and diseases show moderate heritability, including cardiovascular disease 4 and impaired physical functioning 5 , independent of known environmental risk factors.
Inherited genetic variations in DNA sequences come in several forms, including singlenucleotide polymorphisms (SNPs), insertions/deletions and copy-number variations. Of the 54 million variants documented in dbSNP 6 >88% are single base-pair substitutions or 'SNPs' 7 . SNPs located close to one-another are more likely to be inherited together (called linkage disequilibrium) 8 and this tendency coupled with new array technology allows the assaying of millions of SNPs per sample, capturing most common variation.
The effect a variant has on a given phenotype depends on its position in the genome.
Within each gene only a small proportion of the DNA sequence is used as a template for assembling amino-acids into specific proteins 9 (Fig.1) ; these DNA sections are termed exons. Exon sequences are 'transcribed' (in part or in full) from DNA into messenger RNA (mRNA), which undergoes 'processing' before forming the template for protein production. If the DNA sequence within an exon is changed, this could have profound consequences to the final structure of the protein synthesized from the gene. However, the protein-coding regions of genes are highly conserved, even between species 10 . This highlights an intriguing question; if highly similar genes are used in the growth and development of different organs, tissues and cell-types in individuals, how can so much phenotypic variation occur? The answer lies in the complex machinery that regulate gene transcription and protein production in different cells types and in response to specific stimuli.
Transcription can vary in amount (i.e. particular mRNAs can be up or down regulated) but can also produce specific versions or 'isoforms' of proteins, in a fine tuning system that contributes to specialization of cell types and tissues. This involves the removal, or 'splicing', of introns -sequences of DNA that separate the exons from one-anotherallowing many protein products to be derived from a single gene. Transcription and RNA processing require extensive regulation by transcription factors binding to sites in proximity to the gene, which can be many thousands of base pairs away. DNA variants located within these regulatory binding sites can alter when, where and for how long a gene is expressed by altering the affinity of the various transcription factors to that particular regulatory sequence (Fig.1) .
Differential regulation of genes -both in location and timing -between species likely contributes to the divergence and isolation of different species 11 . Human studies are lacking, but work in mice has shown regulatory differences between sub-species 12 .
Affordable genomic array technologies that measure the expression of thousands of genes are now being used in human population studies. Progress in this field is likely to receive a boost in the coming years as studies use large sample collections to investigate the differential regulation of gene expression in humans, and how these differences influence disease and longevity 13 .
Epigenetic changes, such as DNA methylation and histone modifications, are also heritable and affect mRNA expression 14 . These changes to the structure of DNA do not affect the sequence, and can change with advancing age 15 . 
SNPs and age related diseases
In the early 2000s, many correlations between SNPs and specific disease were reported from relatively small-scale volunteer and population studies, but unfortunately multiple statistical testing and a bias towards reporting positive results contributed to many of these reports being unreliable, with inflated effect sizes and replication efforts failing to confirm claims 17, 18 . this has since been replicated in larger studies 21, 22 . As complement factor H (part of a specialized inflammatory cascade) had previously attracted limited attention in AMD research, GWAS had provided a powerful insight into the underlying mechanisms of the condition; at present 40% of the heritability of AMD has been accounted for by 5 SNPs
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. Similar insights into the mechanisms underlying menopause, a key aging trait in humans, have very recently emerged from a meta-analysis of numerous studies 24 .
Variants related to DNA repair and immune pathways emerged as important.
Using the catalogue of published GWAS results 25 we have re-examined the results for 4 common age-related diseases (ARDs) for this review, to illustrate the lessons being learned from GWAS about the biological architecture of these conditions. We have Of the SNPs associated with these 4 ARDs only one is not unique to a single disease (rs2075650 increases risk of both Alzheimer's and cardiovascular disease). A critical feature of the identified SNPs is that very few are in protein-coding regions (4% of these ARD related SNPs are classified as exonic), therefore most do not directly alter the amino acid sequence of the protein product (Fig.2) . We therefore identified the nearest genes to each SNP, as the most likely genes affected, although in most cases the mechanisms of effect have yet to be confirmed. Only 5 of the 89 ARD SNP nearest genes are associated with more than one ARD; MTHFD1L (AD and CVD), OASL (CVD and T2D), SLC22A3 (CVD and PC), THADA (PC and T2D) and TOMM40 (a proxy for the ApoE haplotype, for AD and CVD). In general therefore, our exemplar ARD appear to be complex polygenic traits (i.e. influenced by many genes of small effect) and these risk traits appear to be largely inherited separately in each individual. We note however that much variation remains unaccounted for, but it is likely that this unexplained heritability will be accounted for by large numbers of very small effect common variants, rare moderate effect variants 26 or perhaps epigenetic effects. Another contributor to the missing heritability might be that heritability estimates are uncertain: twin studies have estimated the genetic heritability of AD anywhere between 36% 27 and 74%
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, partly depending on definitions used.
Biological pathways implicated in ARD SNPs
As noted for macular degeneration, the results from SNP studies can give a powerful indication of the biological pathways contributing to each trait. Using this principle we have analyzed the GWAS results for 4 common ARDs to identify the affected biological pathways. Using the published GWAS results 25 we extracted the SNPs listed for the 4 common ARDs mentioned above. SNP annotations (mapped genes) were determined using SCAN 29 . We used BiNGO 30 software to determine which biological processes (as defined by Gene Ontology SNPs affecting the risk of developing prostate cancer are largely in development and proliferation related processes. Although some of the processes seem specific to certain organs, the underlying development mechanisms involve similar pro-growth and development genes. Given that cancer is a disease of faulty control over cell proliferation or apoptosis, components of these pathways, or similar, would be expected to be overrepresented in the genes associated with susceptibility to prostate cancer.
Given that the causes of Alzheimer's disease (AD) are still largely mysterious, the 
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Although a few ARD associated SNPs may involve amino acid changing variants (e.g. the R325W variant in SLC30A8 gene, the P12A variant of the PPARG gene and the E23K variant of the KCNJ11 gene for type 2 diabetes) 37, 38 , it is striking that over 98% of all variants are located in 'non-coding regions' of the genome 6, 7 (Fig.2) , only 60% are predicted to alter the final protein sequence (similar proportions in GWAS results: <5% of reported SNPs change the final protein sequence, ~46% intergenic, ~41% intronic, the rest are in other untranslated regions (UTRs)). Although these non-translated regions of the genome produce no proteins, there is growing evidence that they are far from nonfunctional 39 .
Genetic variants in non-translated regions may affect factors necessary for epigenetic modifications, such as histone modification, chromatin remodeling, miRNA (microRNA) regulation of transcription or DNA methylation. These factors are recognized as important regulators of the activity of many genes, including those involved in glucose metabolism 40, 41 . Variants located within a regulatory region of a transcript (for instance the UTRs) may interfere with the efficiency of transcription or translation ( Fig.1 ), as has been recently shown for several human and rodent genes [42] [43] [44] . Variants located in introns may be present in uncharacterized exons, or may influence mRNA splicing 45 ; the production of aberrant splice products is an important disease mechanism 46, 47 . Finally, SNPs located in intergenic regions may act through natural antisense transcripts (NATs) 48 or be located in uncharacterized regulatory regions as was described in 2008 for the OCA2 gene involved in determination of eye color in humans 49 .
Most of the non-coding regulatory regions are involved in the generation of tissue specificity, adaptation or response to the intra-and extracellular environment. Alternative splicing, for example, is a pivotal mechanism in ensuring cellular plasticity. It is noteworthy that organisms such as the dinoflagellates that do not exhibit phenomena such as alternative splicing have a great many more genes (up to 87,688) 50 than do higher organisms such as humans (~23,000 genes). In order to make any further inference about how variation at the DNA level leads to changes in gross phenotype we must now look downstream at changes in gene expression associated with genetic variation, aging and age-related disease.
Comparison with laboratory models of aging
Laboratory models typically used to study aging, such as C. elegans (nematode worm)
and Mus musculus (mice), have drastically shorter lifespans than our own (~3 weeks 51 and ~3 years 52 respectively, versus a 122 year maximum for humans thus far 53 ). In some respects these models are ideal for study in the laboratory (higher turnover, controlled environment), yet applicability to humans can be elusive due to the inherent inter-species differences. For instance, whilst we may share a large portion (over 98.5%
identical in protein-coding regions 54 ) of our genome with chimpanzees -our closest relative in evolutionary terms -we have evolved distinct phenotypic differences, including aging at a slower rate. These differences will only be more exaggerated in more distantly related species (such as the worm and mouse models). There are however similarities between aged humans and aged model organisms; they all tend to have decreasing overall fitness, and therefore studies using model organisms continue as they may be at least indicative of some aging mechanisms in humans.
Extensions to lifespan in model organisms are mostly associated with disruption to fundamental metabolic pathways, with target genes showing conservation across species. For example, 'knockout' mutations in the IGF1/insulin pathway can double lifespan in C.elegans in the laboratory environment 55 , and some have argued that this is directly relevant to humans. However, aging traits in higher organisms are likely to be largely influenced by complex and cell type specific regulatory sites, as noted above.
Given the barriers against experimental studies of in-vivo regulation and aging in humans, epidemiological studies combining genetic and gene expression data will be crucial in determining the relevance to humans of molecular mechanisms identified in laboratory models.
Gene expression arrays
Messenger RNA (mRNA) is a key intermediate between DNA and proteins (Fig.1) 56 have shown that ~17% of genes are differentially expressed between 2 populations of distinct ethnic decent, which is due to differences in inherited variation and lifestyle (environment) 57 .
Microarrays are used to quantify the expression of thousands of mRNA molecules from a single sample. Many gene expression studies in laboratory models of aging have been reported: see the database of age-related genes 58 . Until recently however studies in humans were based on very small sample sizes, risking the same reliability problems that beset candidate SNP studies. As microarray cost has come down drastically in recent years it is now feasible to study large numbers of samples at once.
In humans major early studies focused on, for example, gene expression in muscle biopsy material 59 and identifying genes associated with age in the San Antonio Family
Heart Study frozen lymphocyte samples 60 . , and the majority of these were down-regulated. Using gene ontology information in a pathways-based analysis we found that the most deregulated biological processes across the age range are related to RNA processing 31, 62 . mRNA splicing is the process that allows a single gene to code for more than one transcript ('isoform'), which may have a different function, temporal or spatial expression pattern to an alternative isoform from the same gene. The implications of this finding are wide-ranging; a decrease in the production of mRNA splicing factors is indicative of a general loss of specificity or 'fine tuning'-the alternative forms of genes will be less common in the older individuals. This may mediate some of the decreased 'fitness' and declining ability of cells to respond to stresses with advancing age.
Using only 6 of the mRNA probes studied, it was possible to very efficiently distinguish between old and young individuals in a independent confirmatory subset of study respondents (for methods and detailed results see the paper 32 ), suggesting that gene expression biomarkers of human biological aging may soon be validated.
Gene expression and age-related traits
Age-related pathologies themselves can also reveal mechanisms intrinsic to the aging process. Loss of muscle strength is a characteristic feature of aging, and can lead to sarcopenia and frailty. We found that the strongest gene expression association with muscle strength in our human subjects pinpointed a highly plausible mechanism. After adjustment for confounding factors, a transcript of CCAAT/enhancer-binding protein-beta (CEBPB) showed the strongest association with human strength, across a wide age range 63 . CEBPB is a gene involved in the maintenance and repair of damaged muscle fibers by macrophages. A mouse model of disrupted CEBPB signaling produced myocyte loss and fibrosis, reminiscent of sarcopenia 64 . Finding, for the first time, that CEBPB expression is so closely associated with human muscle strength suggests that the macrophage mediated repair pathways should be a priority for investigations of age related declines in muscle, particularly in light of recent findings that strength is predictive of mobility decline in older adults 65 .
We have also examined expression associations with cognitive function, using the mini mental state examination (MMSE) score 66 . It has been argued that chronic inflammation contributes to impaired cognitive function and dementia 67, 68 , so we expected to find many related expression correlates. In fact, we found that the strongest association was with a single chemokine receptor (CCR2), with little other robust evidence of gene expression deregulation (Fig.3) . CCR2 is involved in the macrophage response to atherosclerotic plaque formation and in brain microglia. Blocking CCR2 signaling in mice models of Alzheimer's disease resulted in accelerated Alzheimer's-like pathologies 69 and transplantation of 'normal' hematotpoietic CCR2 competent monocytes restored memory capacities 70 . This is another strong indication of concordance between human in-vivo leukocyte gene expression and one of the many laboratory models of Alzheimer's disease.
While gene expression studies in humans therefore appear promising, there remain major challenges. As noted above, gene expression can be affected by confounders such as lifestyle and ethnicity 57 . RNA is an unstable molecule and specimen handling is a challenge. Perhaps the greatest challenge in studying human aging is the limited access possible to many tissues of interest. Nevertheless, expression arrays using RNA from available tissues such as blood are helping to identify novel age related expression signatures and have pinpointed concordance with specific laboratory models of key traits.
Could genomics be part of ARD risk or diagnostic testing?
In the excitement of the human genome sequencing project, many argued that genomics would predict common diseases and personalize treatment. However, this optimism waned as it became clear that most common diseases are influenced by very large numbers of variants of small effect (plus strong environmental influences), and that much variation is still unaccounted for 71 .
One of the first SNPs to be identified for type 2 diabetes was the TCF7L2 variant, which was associated with a significant increase in risk (OR = , although the prediction is never likely to be precise. Adding gene variant panels into screening program algorithms may also be of some utility, for example in breast cancer screening 75 .
The key to a useful test is, of course, having an effective intervention to offer if the test is 'positive'. The success in identifying a good proportion of the heritability in age-related macular degeneration is likely to be translated into a useful predictive test when a preventive treatment becomes available. Each clinical application however needs to be properly investigated using a systematic approach to test evaluation, as initial data in preselected case and control groups tends to seriously exaggerate test efficiency 76 .
In addition to risk prediction, there is some optimism about the potential for ARD variants to identify new drug targets: for example, six type 2 diabetes variants are in or near targets for existing drugs, and there is therefore optimism that novel SNP loci might lead to new drug targets 77 .
In contrast to SNP based tests, gene expression markers are already being used to guide disease sub-typing and treatment selection, notably in breast 78 and other cancers.
The tests involved use mainly tumor tissue itself as the source of mRNA, but extension of this approach to identifying gene expression 'signatures' early in disease processes seems likely. In the case of age related changes we have shown that a panel of 6 markers related to immunity and inflammation, maintenance/development of muscle tissue and vascularization are highly predictive of age in a confirmatory subset 32 , but such expression gene signatures of aging will need extensive and independent validation.
Conclusions
Aging is a heterogeneous process that includes rapidly rising risks of age-related 
